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“Can the brain understand the brain? Can it understand the mind?  
Is it a giant computer, or some other kind of giant machine, or something more?” 
– David H. Hubel 
 
This past decade has seen this idea of “something more” expand to the trillions of bacteria 
within the gut, the microbiota (Cryan et al., in press; Rhee et al., 2009). Indeed, there has 
been an explosion of research investigating the microbiota and its contribution to all aspects 
of human health and disease including psychological well-being and neurodevelopment. But 
what exactly is the microbiota? It is defined as the collection of micro-organisms, including 
bacteria, viruses, fungi, and archaea, which reside in a particular niche (note that the 
‘microbiome’, although often used interchangeably with ‘microbiota’, refers to both the 
community and its collective genome). It has been estimated that the human microbiota 
contains 3.8 x1013 bacteria, more than the number of human cells in the body (Sender et al., 
2016), with its genome outnumbering human genes by up to 150:1 (Qin et al., 2010). The 
largest of these microbial communities resides within the gastrointestinal tract, with the gut 
microbiota playing a key role in extracting nutrients from the diet and training the immune 
response at the body’s largest immune interface (Gensollen et al., 2016). The gut microbiota 
is therefore the subject of the vast majority of research regarding the impact of the microbiota 
on brain and behavior. In this review we focus on the gut microbiota as a key regulator of 
brain and behavior in early life. We will first examine what is known about the 
developmental trajectory of the microbiota and propose that there are sensitive periods in the 
microbiota-gut-brain axis with consequences for neurocognitive development. We will then 
provide evidence for this hypothesis based on studies of both humans and non-human 
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animals, examine potential mechanisms for interactions between the developing microbiota 
and neurodevelopment, and finally discuss challenges for translational research in this area. 
 
1.1 The Development of the Microbiota 
Using the latest sequencing technologies, a clearer picture is beginning to emerge of how the 
gut microbiota develops over the lifespan and how this influences the host (see Box 1 for 
further information on how the microbiota is measured). Whether microbial colonization 
occurs in utero is currently the subject of heated debate (Perez-Muñoz et al., 2017; Walker et 
al., 2017). What is clear is that the microbiome is rapidly populated at birth (Ferretti et al., 
2018). This initial seeding and the subsequent development of the microbiota is dependent on 
many factors (see Box 2 and Figure 1), but there are some clear trends across maturation. At 
least in vaginally-delivered babies, the majority of early gut colonizers are transmitted from 
the maternal microbiota (from various sites, but predominantly the maternal vaginal and stool 
microbiota; Ferretti et al., 2018). After the first few days, there is a slow increase in the 
number and diversity of species represented, shifting from mostly aerobic or facultative 
species (that can survive in oxygenated environments) towards more anaerobic species 
(Ferretti et al., 2018; Timmerman et al., 2017). The early microbiota seems to be geared 
towards extracting nutrients in order to support the rapid development of the brain and body 
of the host (Hollister et al., 2015; Koenig et al., 2011). There is another rapid burst in 
development of the microbiota at weaning, as the infant shifts from exclusive breastfeeding 
or formula intake to a solid diet (a pattern observed across species, including humans and 
rodents; Al Nabhani et al., 2019; Guevarra et al., 2018; Koenig et al., 2011; Stewart et al., 
2018; Yatsunenko et al., 2012). According to some studies, weaning is followed by a period 
of relative stability in the microbiota (Stewart et al., 2018; Yatsunenko et al., 2012). 
However, other results suggest there is ongoing change and plasticity across middle 
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childhood and adolescence (for a review, see Derrien et al., 2019). These investigations have 
shown that developing individuals continue to exhibit microbiota differences from adults well 
into adolescence, in a pattern that seems to indicate gradual development towards an adult-
like profile (Agans et al., 2011; Hollister et al., 2015).  
 
Box 1. Measuring the Microbiota 
The most commonly used techniques for measuring the microbiota are high-throughput 
sequencing methods such as 16S rRNA sequencing and shotgun metagenomics. Using these 
methods, we can identify the composition of the microbiota (i.e., who is in there, based on the 
genetic read-out) and the functional potential of the community (i.e., what are they doing?; 
see Bastiaanssen et al., 2019; Claesson et al., 2017 for summaries of these techniques, written 
for clinicians). Different measures of diversity are usually used to describe and compare the 
output of these analyses, with the two main metrics being alpha and beta diversity.  
 
Alpha diversity. Refers to diversity within a given microbial community. Counting the 
number of species present is one simple way to estimate diversity (more species = more 
“richness” ≈ more diversity). Some measures of alpha diversity also take into account the 
“evenness” of a community, which refers to the balance of different species (similar numbers 
of each species = more evenness ≈ more diversity). Other measures take into account the 
phylogenetic relatedness of the community members (more closely related species ≈ less 
diversity). Examples of common alpha diversity metrics include the Chao1, Shannon, and 
Simpson’s Indices. 
 
Increased alpha diversity is commonly interpreted as an indicator of a healthier microbiota. 
This is based on the assumption that diversity increases the capacity of the community to 
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perform a broader range of functions and resist invasion from pathogens. However, more 
diversity is not always better and we should be particularly wary of such simplistic 
interpretations in the context of development. 
 
Beta diversity. Refers to the differences between two (or more) microbiota. As for alpha 
diversity, different metrics may take into account different factors such as phylogenetic 
relatedness. Beta diversity is usually shown using a principal component analysis (PCA) plot 
or similar data simplification method to represent the complex microbial communities in just 
2-3 dimensions. In these plots, the further apart two communities are, the more different they 
are and thus the higher their beta diversity. 
 
 
Box 2. Factors that Shape the Developing Microbiota 
Starting even before birth, there are many factors that shape the developing microbiota. These 
include, but are not limited to, genetics, stress, mode of birth, diet, infection or disease, 
medication (including antibiotics), and environmental factors. Overall, the responsive nature 
of the microbiota offers a potential advantage when it comes to targeting disease. 
 
Genetic Factors. Studies of the relationship between host genetics and the microbiota have 
discovered and validated many heritable gut bacteria in humans (Goodrich et al., 2016; 
Goodrich et al., 2014; Lim et al., 2017; Turpin et al., 2016). However, a large proportion of 
the microbiota is not heritable and environmental factors explain far more of the variation in 




Stress. Stress influences all levels of the microbiota-gut-brain axis, particularly in the early 
stages of development. Both pre- and post-natal stress are established risk factors for the 
development of psychological and neurodevelopmental disorders (Kessler et al., 2010; Kim 
et al., 2015), as well as gastrointestinal problems and/or microbiota alterations (Callaghan et 
al., in press; Michels et al., in press; Pohl et al., 2015). These observations in humans are 
reflected in experimental animal models of early-life stress, which have long been used to 
model both psychological and gastrointestinal disorders (O'Mahony et al., 2011). Moreover, a 
number of recent studies have demonstrated links between prenatal stress (including maternal 
anxiety) or early-life adversity and alterations in the human microbiota across the lifespan 
(Callaghan et al., in press; D’Agata et al., 2019; Hantsoo et al., 2019; Hemmings et al., 2017; 
Hu et al., 2019; Labus et al., 2017; Michels et al., in press; Zijlmans et al., 2015). 
 
Mode of delivery at birth. Parturition acts as the first large-scale exposure to environmental 
microbes and mode of delivery has a profound effect on the initial composition of the infant 
microbiota (Stewart et al., 2018). Vaginally-delivered babies are exposed to microbes 
resident in the maternal birth canal, whereas babies born via Caesarean section exhibit a 
microbiota profile that more closely resembles adult skin and/or hospital microbiota 
(Dominguez-Bello et al., 2010). This effect of delivery mode emerges in the transitional stool 
rather than the meconium (i.e., the first stool after birth), but dissipates within a few 
weeks/months of birth (Chu et al., 2017; Hill et al., 2017; Stewart et al., 2018). 
 
Diet. During infancy, one of the most robust microbiota findings is that formula- and breast-
fed infants exhibit divergent profiles, with cessation of breastfeeding accelerating the 
development of the microbiota (Stewart et al., 2018). In cases of childhood malnutrition, the 
maturation of the microbiota is delayed, an effect that is only partially or temporarily restored 
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by dietary intervention (Smith et al., 2013; Subramanian et al., 2014). Diet continues to play 
an important role in determining microbiota composition throughout life; even short 
manipulations of diet in adulthood can have rapid effects on the microbiota (David et al., 
2014; Johnson et al., 2019). This is intriguing given that diet tends to change over the 
lifespan, with adolescents being particularly prone to poor food choices, in combination with 
drug and alcohol experimentation, at a time when their microbiota and brains are still 
developing (Flannery et al., in press; McVey Neufeld et al., 2016). 
 
Medical factors. Bacterial or viral infections, gastrointestinal problems (e.g., diarrhea), and 
antibiotic use are obvious sources of variation in the microbiota (Mortensen et al., 2018). 
However, other non-antibiotic medications (including many targeting neurological or 
psychological problems) have also been shown to alter the growth of certain gut bacteria in 
vitro as well as overall microbiota composition in rodents (Cussotto et al., 2018; Maier et al., 
2018). In adult humans, bariatric surgery results in substantial changes to the microbiota 
(Guo et al., 2018). There is also a rich literature showing that premature infants, who 
typically undergo multiple medical procedures in the early stages of life, exhibit microbiota 
alterations (Chernikova et al., 2018; La Rosa et al., 2014; but see also, Stewart et al., 2018). 
 
Environmental factors. Many facets of day-to-day life contribute to microbial exposure and 
therefore to the microbiota. Urbanization (encompassing less contact with the natural 
environment and accompanying changes in diet), pet ownership, and increasing use of 
antibiotics and disinfectants are all factors that alter microbial exposure and have been 
associated with altered microbiota (Ayeni et al., 2018; De Filippo et al., 2017; Stewart et al., 





Figure 1. Many factors affect the developing microbiota and may therefore alter the 
developmental trajectory of the microbiota-gut-brain axis. See Box 2 for further discussion. 
 
Intriguingly, periods of change in the microbiota coincide with times of rapid development in 
other bodily systems and particularly the brain (Borre et al., 2014). This parallel development 
is likely to be biologically relevant, and we hypothesize that these developmental windows 
correspond to sensitive periods in the microbiota-gut-brain axis.  
 
1.2 Sensitive Periods 
Sensitive periods (often used synonymously with the terms “critical periods” and “critical 
windows”) are defined as specific developmental windows during which a system exhibits 
heightened plasticity and is particularly responsive to certain environmental cues. These cues 
(also known as “expected inputs”) are used to tune the system in a highly efficient manner. 
The classic experiments by Nobel prize winners Hubel and Wiesel showed that deprivation of 
light input into one eye permanently changes the activity of neurons in the cerebral cortex of 
cats, but only during a narrow developmental time window (Hubel & Wiesel, 1970). Later 
exposure to light was insufficient to reverse the changes that occurred during the sensitive 
period, while depriving an eye of light outside the sensitive period had little effect on 
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neuronal activity or vision. The existence of such sensitive periods optimizes systems 
development when certain experiences (like exposure to light) reliably occur during certain 
stages of development (during the time of first eye opening). 
 
Sensitive periods have now been described for other, more complex brain functions and 
behaviors such as language (Werker & Hensch, 2015) and emotional learning (Alberini & 
Travaglia, 2017; Gogolla et al., 2009; Hartley & Lee, 2015). Particularly for these higher 
order functions, there is not just one critical window but a cascading series of sensitive 
periods with intricately linked timing, each dependent on the preceding experiences. 
Furthermore, the timing of onset and offset of the sensitive period is less well-defined for 
these higher order functions, at least in part due to the extended development of the 
supporting brain regions (Tottenham, 2017). Even the most well-defined sensitive periods 
exhibit a gradual decline in plasticity, subthreshold responses to the expected inputs into 
adulthood, and potential to be re-opened by pharmacological or environmental manipulations 
(Morishita & Hensch, 2008). This latter property has great therapeutic application, offering 
hope for effective intervention even after the closure of a sensitive period. 
 
1.3 Sensitive Periods in Microbiota-Gut-Brain Axis Development 
We hypothesize that signals from the microbiota are required for certain functions, acting like 
an expected input (similar to the role of the light in the original Hubel and Wiesel 
experiments) to calibrate the microbiota-gut-brain axis. The absence or disruption of the 
microbiota during specific developmental windows would therefore have a disproportionate 
effect on specific functions that are relevant to the time window of disruption and potentially 
for regulation of the system as a whole. In addition, external cues such as changes in diet and 
exposure to environmental microbes may be considered expected inputs for the developing 
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microbiota (see Box 2). Multiple sensitive periods likely occur across the development of the 
microbiota-gut-brain axis, just as there are multiple sensitive periods within each domain of 
neurodevelopment (see Figure 2). While these ideas are still in a preliminary phase of testing, 




Figure 2. Sensitive periods, or critical windows of heightened plasticity, occur in a cascading 
fashion across human development, with multiple critical windows for each functional 
domain (shown on the upper axis). The timeframes for peak plasticity in the microbiota (in 
the early post-natal period, at weaning, and possibly again at adolescence; lower axis) overlap 
with these trajectories and also coincide with peaks in the onset of neurodevelopmental 
disorders (shown in black). Note that, compared to the brain, the microbiota exhibits a 
relatively high level of ongoing plasticity beyond the developmental period.  
 
The microbiota itself seems to be especially sensitive to disruption during early life. Although 
its composition continues to be malleable to some extent throughout life, it has been 
hypothesized that early colonizers, or “founder species”, in the gut have a disproportionate 
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influence on the ultimate steady-state composition of the microbiota (Litvak & Baumler, 
2019). The nature of the maturational trajectories of the microbiota also makes it more 
responsive to external influences during development. The postnatal microbiota is relatively 
volatile, gaining stability across maturation (Koenig et al., 2011; Stewart et al., 2018; Yee et 
al., 2019), perhaps due to the increasing diversity described in Section 1.1 above. Periods of 
microbiota instability also occur during later phases of development, with a clear shift at 
weaning and an understudied transition considered likely during the adolescent period 
(Figure 2). Given the dearth of longitudinal studies examining patterns of microbiota 
development beyond infancy, there may very well be other sensitive periods in between (see 
Derrien et al., 2019 for a discussion of the pre-school and primary school years). 
 
There is additional evidence that the microbiota is particularly influential on the gut-brain 
axis during development. It has recently been shown that the natural course of microbiota 
maturation at weaning is crucial for development of the immune system, one of the key gut-
brain pathways (Al Nabhani et al., 2019). Weaning induced a sudden change in the 
composition of the microbiota, with an associated spike in inflammatory activation that was 
termed the “weaning reaction”. Using several elegant methods to alter the timing of weaning 
or suppress the weaning reaction, it was demonstrated that such disruptions to the 
developmentally appropriate timing of the weaning reaction led to pathological imprinting of 
the immune system, increasing risk for various inflammatory disorders in response to later 
immune challenges. 
 
Taking a further step into the microbiota-gut-brain axis, there are now several examples that 
support the idea of critical windows for microbiota modulation of brain and behavior in 
animals. Studies where germ-free rodents have been re-colonized with “normal” microbiota 
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(i.e., from specific pathogen-free animals) at different ages have shown that post-weaning re-
colonization is more effective at restoring germ-free deficits than re-colonization later in life, 
at least for specific aspects of brain or immune function and behavior (Buffington et al., 
2016; Diaz Heijtz et al., 2011; Olszak et al., 2012; Sudo et al., 2004). For example, social 
deficits in germ-free mice were reversed by re-colonization at weaning but not by re-
colonization 4 weeks later in adulthood (Buffington et al., 2016). Still other functions in 
germ-free animals cannot be restored by re-colonization even at the time of weaning, hinting 
that the window for microbial influence on these functions is already closed by the age of 
weaning (e.g., Clarke et al., 2013). In support of the translational value of the sensitive 
periods hypothesis, two studies of childhood antibiotic exposure have reported that exposures 
in the first year of life, but not at later time-points, have a negative impact on cognitive 
development (Slykerman et al., in press; Slykerman et al., 2017; although see Section 2.1 for 
a discussion of limitations in these studies). 
 
2. Evidence for Microbial Modulation of Neurocognitive Development 
2.1 Behavioral and Cognitive Development 
Human Studies. Two studies, including a recent investigation of a large Finnish cohort, have 
observed complex, sex-specific relationships between the microbiota composition and very 
early temperament, including extraversion, regulation, and fear reactivity (Aatsinki et al., in 
press; Christian et al., 2015). Gastrointestinal distress, which is associated with disruption of 
the microbiota, has been shown to predict future anxiety across childhood, even when 
accounting for initial anxiety (Callaghan et al., in press). The evidence for microbiota 
modulation of psychological or behavioral outcomes in pediatric populations with a physical 
illness is limited and mixed (Kan et al., in press). However, there are some promising studies 
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suggesting that modulation of the microbiota can improve behavioral symptoms of 
neurodevelopmental disorders (see Section 4.1). 
 
With respect to cognitive development in humans, we are aware of just one study that has 
directly measured both the microbiota and cognitive performance, which is part of the 
ongoing University of North Carolina Early Brain Development Study (Carlson et al., 2018; 
Gao et al., 2019). In that cohort of 89 infants, the community structure (i.e., beta diversity) of 
the fecal microbiota at one year of age predicted cognitive performance on the Early Learning 
Composite (a global cognitive index) of the Mullen scale at 2 years. This effect was driven by 
differences in the receptive and expressive language domains. Alpha diversity at 1 year of 
age was also predictive of cognitive performance, as indicated by negative correlations 
between alpha diversity and the overall Early Learning Composite, expressive language 
scale, and visual reception scale at 2 years of age.  
 
Finally, there have been some preliminary human developmental studies examining both 
neural/cognitive and behavioral outcomes in relation to early-life microbiota manipulations. 
It has been reported that antibiotic use in the first year of life has a detrimental effect on 
overall IQ and reading ability during the primary school years (Slykerman et al., 2017). Such 
early-life antibiotic exposure was also associated with greater behavioral difficulties, more 
oppositional behavior, and more symptoms of ADHD and depression. However, the strength 
of these proposed microbiota-cognition and microbiota-behavior relationships is difficult to 
ascertain as the researchers did not directly examine the microbiota nor collect data on the 
reasons for antibiotic use. The same research group later conducted a placebo-controlled trial 
of two probiotic strains administered throughout pregnancy and the first two years of life. In 
that sample, which exhibited high rates of antibiotic use (>80% in the first 2 years, similar 
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across treatment groups), there were no significant effects of either probiotic on cognitive or 
behavioral outcomes at 11 years of age (Slykerman et al., 2018), although the effect of early-
life antibiotics was replicated (Slykerman et al., in press). However, again, this study had 
several limitations; there was no justification provided for the choice of probiotic strains, the 
doses, or the methods of administration, nor was there a measure of the microbiota across 
treatment (problems that are common in this area of research). Finally, a recent study of 
premature infants in a Neonatal Intensive Care Unit (NICU) also examined the effect of 
perinatal antibiotics administered either to the mother during gestation or to the infant during 
the NICU stay (Firestein et al., 2019). In this study, which excluded cases of confirmed sepsis 
to reduce the confounding effect of infection, perinatal antibiotic exposure was associated 
with increased attentional problems at 4-5 years of age. Antibiotic-exposed children also 
exhibited higher delta power on an electroencephalogram (EEG), a pattern observed in 
ADHD and interpreted as a delay in maturation. Finally, an intervention that encouraged 
physical contact (and therefore transmission of microbes) between parent and infant during 
the NICU stay reduced the risk for both behavioral and neural alterations (Firestein et al., 
2019). In addition to this preliminary evidence for microbiota modulation of developmental 
outcomes in humans, there have been many more studies using animal models to explore 
different aspects of cognitive and behavioral development. 
 
Animals - Social Behavior & Cognition. Perhaps the strongest evidence for microbial 
modulation of cognition and behavior in animal models comes from studies of social 
interactions (Sherwin et al., in press). Germ-free rodents typically exhibit deficits in both 
sociability and memory for social stimuli (indexed by preference for a novel social partner; 
Buffington et al., 2016; Desbonnet et al., 2014; Sgritta et al., 2019; Stilling et al., 2018) (but 
see also Arentsen et al., 2015). Similar effects are observed following antibiotic depletion of 
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the microbiota during development (Degroote et al., 2016; Desbonnet et al., 2015), while 
administration of certain probiotic species can enhance social behavior in various murine 
models of autism (Buffington et al., 2016; Hsiao et al., 2013; Sgritta et al., 2019) and 
inflammation-induced social withdrawal (D'Mello et al., 2015). In fruit flies (Drosophila 
melanogaster), both developing and mature individuals rely on microbiota-derived volatile 
compounds as social signals, influencing food and mating preference (Sharon et al., 2010; 
Venu et al., 2014). This is reminiscent of the associations between microbiota composition 
and extraversion observed in human infants, as described above (Aatsinki et al., in press; 
Christian et al., 2015). Thus, there is a robust relationship between social behavior and the 
microbiota observed across species. It has been hypothesized that this relationship has an 
evolutionary basis, driven by the mutual benefits of social interaction for both host and 
microbiota (Stilling et al., 2014). That is, social interaction encourages propagation and 
transfer of microbes to different hosts and simultaneously increases diversity in the 
microbiota of any particular individual, with potential benefits for satisfying the nutritional 
and health needs of the host. 
 
Animals - Learning and Memory. Germ-free studies have demonstrated that rodents reared 
without a commensal microbiota exhibit exaggerated conditioned fear responding (Hoban et 
al., 2018), but impairments in object recognition memory and working memory on a 
spontaneous alternation test in adulthood (Gareau et al., 2011; Luk et al., 2018). Antibiotic 
administration from adolescence or adulthood has a similar effect on the novel object task, 
impairing recognition memory (Desbonnet et al., 2015; Fröhlich et al., 2016). The effects of 
antibiotic administration on spatial memory performance are more mixed, with one 
developmental study finding that early-life antibiotic treatment did not alter spatial memory 
in adulthood (O'Mahony et al., 2014), despite other evidence that chronic antibiotics impair 
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spatial memory in adult rats (Hoban et al., 2016a; Wang et al., 2015). These differences may 
be attributable to differences in the antibiotic regimen and rodent species; further 
developmental studies would be useful to understand the discrepancy. 
 
Dietary interventions have shown promise in reducing the impact of stress or other 
microbiota perturbations on learning and memory outcomes across the lifespan. In adult 
rodents, probiotic supplementation has been used to reverse spatial memory deficits 
following stress, infection, or antibiotic treatment (Gareau et al., 2011; Liang et al., 2015; 
Wang et al., 2015), and even to provide benefits in healthy animals in terms of spatial 
memory, object recognition memory, and long-term fear memory (Savignac et al., 2014). 
During adolescence, dietary supplementation with omega-3 polyunsaturated fatty acids and 
vitamin A restored cecal microbiota composition and novel object recognition impairments 
following chronic social instability stress (Provensi et al., in press). Earlier in development, 
specific probiotic strains (Lactobacillus rhamnosus and Lactobacillus helveticus) rescued the 
expected developmental patterns of conditioned fear behavior in infant rats exposed to early-
life maternal separation stress (Callaghan et al., 2016; Cowan et al., 2016b). Stressed infants 
exhibit more persistent fear memories and are more vulnerable to relapse following fear 
extinction, but both these behavioral abnormalities are reversed by probiotic treatment (an 
effect demonstrated in two separate labs; Cowan et al., 2016a; Peng et al., 2019). 
Remarkably, the probiotic treatment is even effective to prevent the generational transmission 
of these stress-induced behavior changes (Callaghan et al., 2016). 
 
2.2 Brain Development 
Morphology. Studies of the microbiota’s role in human structural brain development are still 
rare. In adults, a cluster analysis identified different microbiota compositions that were 
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associated with different white matter and gray matter signatures, including regional volume 
differences in the right hippocampus, left nucleus accumbens, right anterior occipital sulcus, 
and cerebellum (Tillisch et al., 2017). Alpha diversity in the microbiota has also been linked 
to microstructure of the hypothalamus, caudate nucleus, and hippocampus of obese adults, 
while the relative abundance of a specific phylum, Actinobacteria, correlated with 
microstructure variables in the hypothalamus, thalamus, and amygdala (Fernandez-Real et al., 
2015). In children, there has been just one study examining brain structure and gut 
microbiota, which reported positive associations between alpha diversity at 1 year of age and 
volumes of the left precentral gyrus, left amygdala, and right angular gyrus at 2 years 
(Carlson et al., 2018). The same study also reported specific regional brain volume 
differences based on a cluster analysis of the microbiota.  
 
A more experimental approach was taken in a fecal microbiota transplant study from pre-
term babies in the Neonatal Intensive Care Unit (NICU; Lu et al., 2018). Germ-free mice 
colonized by the microbiota of babies who showed poor growth in the NICU exhibited 
indicators of delayed brain development with respect to markers of neuronal differentiation, 
oligodendrocyte development, and myelination in the cerebral cortex compared to recipients 
of the high-growth microbiota. The microbiota from low-growth babies also affected various 
neurotransmission pathways and increased neuroinflammation while lowering circulating 
levels of growth hormones. 
 
Such extensive changes in the structural development of the brain are similarly observed in 
animal models of microbiota depletion. Germ-free mice exhibit alterations in gross 
morphology, including expansion of the amygdala and hippocampus (Luczynski et al., 2016). 
Morphology of germ-free mice also differs at the neuronal level in a region-specific manner, 
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with hypertrophy of neurons in the amygdala and periaqueductal gray but shorter, less 
complex neurons in the anterior cingulate cortex and hippocampus (Luczynski et al., 2017; 
Luczynski et al., 2016). These structural differences, at least in the hippocampus, are likely 
related to observations of increased rates of hippocampal neurogenesis in both germ-free 
(Ogbonnaya et al., 2015) and antibiotic-treated mice (Möhle et al., 2016). Microbiota-related 
structural brain changes are not limited to the neuronal architecture; germ-free and antibiotic-
induced microbiota depletion also leads to changes in microglia maturation (more immature 
microglia; Erny et al., 2015; Thion et al., 2018b) and levels of myelination (hypermyelination 
of the prefrontal cortex; Gacias et al., 2016; Hoban et al., 2016b), while white-matter 
integrity was associated with diet-induced changes in the gut microbiota in a diffusion tensor 
imaging study of rats (Ong et al., 2018).  
 
Function and Activity. In adult humans, several brain imaging studies have shown that 
probiotic bacteria can alter brain activity in response to emotional stimuli (Pinto-Sanchez et 
al., 2017; Tillisch et al., 2013; Wang et al., in press), while certain microbiota compositions 
are associated with different patterns of brain activity (Tillisch et al., 2017). Metabolic 
function of the microbiota (specifically synthesis of phenylalanine, a dopamine precursor) 
was associated with decreased ventral striatal activity during reward anticipation in a group 
of young adults with or without ADHD (Aarts et al., 2017).  
 
To our knowledge, there are only two published studies examining microbial modulation of 
brain function or activity in children, both of which were published in the last year. In the 
first, functional connectivity of various brain networks was assessed in sleeping 1-year-olds 
(Gao et al., 2019). Alpha diversity of the fecal microbiota correlated with functional 
connectivity in three separate networks: amygdala-thalamic, anterior cingulate cortex-right 
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anterior insula, and supplemental motor area-left parietal cortex. Further, this latter cluster 
was associated with performance on a cognitive assessment at 2 years of age, perhaps 
providing a partial mechanism for the previously described association between the 
microbiota and cognitive performance (Carlson et al., 2018). The second study was a recent 
pilot conducted in 5-11 year-old children exposed to early adversity (orphanage rearing) and 
age-matched controls (Callaghan et al., in press). In this cohort, levels of certain bacterial 
taxa correlated with prefrontal cortex activation to emotional faces. Some of these taxa were 
less prevalent in the children with a history of early adversity, supporting the idea that the 
microbiota acts as a link between early traumatic experiences and alterations in both 
neurodevelopment and psychological risk. 
 
This study fits nicely with observations in animal models of early-life stress. Following 
maternal separation, a rodent model of early-life stress known to disturb the microbiota 
(O'Mahony et al., 2009), rat pups exhibit accelerated maturation of conditioned fear 
responding (Callaghan & Richardson, 2013) and a corresponding increase in activation of the 
prefrontal cortex during expression and inhibition of conditioned fear (Cowan et al., 2019). 
Probiotic supplementation during the stressful period was sufficient to reverse the effects on 
both behavior and prefrontal cortex activation (Cowan et al., 2016b; Cowan et al., 2019). 
Outside the context of stress, there is a strong and growing evidence base for microbial 
modulation of brain function or activity in various animal models (for a comprehensive 
review, see Cryan et al., in press). For example, transcriptomic analysis of the amygdala of 
germ-free animals revealed differential gene expression, exon usage, and RNA editing 
(Stilling et al., 2015). In addition, there are a number of reports of alterations in various 
neurotransmitter systems by manipulations of the microbiota, notably in regards to serotonin 
and BDNF (Bercik et al., 2011; Clarke et al., 2013; Desbonnet et al., 2015; Diaz Heijtz et al., 
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2011; Gareau et al., 2011; Neufeld et al., 2011; Sudo et al., 2004). Together with the studies 
of brain morphology, this body of work highlights the far-reaching influence of the 
microbiota when it comes to brain development. 
 
3. Digging Deeper into Mechanism: Pathways for a Microbial Influence on 
Neurodevelopment 
There are now a number of known communication pathways within the microbiota-gut-brain 
axis, including the vagus nerve, HPA axis, spinal cord, immune system, and peripheral 
transport of metabolites, amongst others. These have been reviewed in detail elsewhere (e.g., 
Cryan et al., in press). Here, we will provide a brief and simplified overview of just some of 
these pathways with a specific developmental focus (see Figure 3).  
 
 
Figure 3. The microbiota-gut-brain axis consists of multiple pathways that allow 
bidirectional communication between the microbiota and the brain. During development, 
some of the key pathways include nutrient extraction, immune signaling, and barrier function, 
as well as neuronal and hormonal signaling along the spinal cord, vagus nerve, and 




3.1 Metabolism and Nutrient Availability 
Perhaps the most parsimonious hypothesis to explain microbial modulation of 
neurodevelopment is that the microbiota is a key source of essential nutrients and energy for 
the growing brain. Certainly, the microbiota is known to convert food components that would 
otherwise be indigestible into products with nutritional or biological value (see Rowland et 
al., 2018; Sela & Mills, 2010, for reviews on this topic, the latter in infants), and nutrition 
itself is a well-established modulator of cognitive outcomes. Breastfeeding, a dietary factor 
that influences microbiota maturation (Ho et al., 2018), has long been purported to improve 
cognitive outcomes (Johnstone et al., 1999), although more recent data indicates that this 
effect is largely accounted for by confounding variables such as maternal intelligence or 
education levels (Walfisch et al., 2013). On the other hand, both specific nutrient deficiencies 
and low overall diet quality are associated with negative long-term impacts on cognitive 
development (Freeman et al., 1980; Tandon et al., 2016), and nutritional interventions in 
vulnerable populations have been shown to improve cognitive outcomes during childhood 
(e.g., Freeman et al., 1980; Isaacs et al., 2009; Lucas et al., 1998). It has been argued that 
these effects need to be considered in terms of the developing microbiota (Goyal et al., 2015). 
In support of this argument, a recent cohort study in Dutch primary school children found that 
the strength of the relationship between pre-school diet and metabolic phenotype was 
dependent on microbiota composition (Zhong et al., 2019). Childhood malnutrition delays 
maturation of the microbiome (Smith et al., 2013; Subramanian et al., 2014), and fecal 
microbiota transplant from undernourished children into rodents or pigs indicates that this 
altered microbiota plays a causal role in the stunting and metabolic problems associated with 
undernutrition (Charbonneau et al., 2016; Smith et al., 2013). These microbiota-dependent 
problems were resolved in both animal models by supplementation with sialylated milk 
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oligosaccharides (Charbonneau et al., 2016). These compounds are typically found in 
breastmilk, act as prebiotics for the microbiota, and were low in the breastmilk of mothers 
with malnourished children. Another recent trial of “microbiota-directed complementary 
food” found promising effects compared to conventional food treatments in both animal 
models and malnourished children (Gehrig et al., 2019). The microbiota-targeted intervention 
supported microbiota maturation as well as biomarkers of growth, neurodevelopment, and 
immune function in malnourished children. Thus, there appears to be an important interaction 
between nutrient availability, the microbiota, and metabolic development whereby feeding 
the microbiota allows the microbiota to feed the developing body and brain. 
 
3.2 Barrier Function 
Between the microbiota and the brain, there are two major barriers: the gastrointestinal 
barrier and the blood-brain barrier (BBB). The permeability of these barriers is particularly 
relevant for transmission of microbiota-derived metabolites and neurotransmitters as one 
conveyor of signals along the microbiota-gut-brain axis; the more permeable the membrane, 
the more signals will be transmitted. There are striking similarities between the two barriers 
(Daneman & Rescigno, 2009). First, the main function of both is to protect against invading 
pathogens and toxins. Second, they share some broad structural similarities, being composed 
of a cellular layer that forms the main physical barrier alongside immune cells (particularly T 
cells at the gut barrier, microglia in the brain) that guard against pathogens (although there 
are also obvious structural differences, including the presence of a mucosal layer in the 
gastrointestinal tract). Third, despite these structural boundaries and the importance of 
separating the inner and outer environments at these critical interfaces, neither barrier is 
completely impenetrable. Rather, both are selectively permeable to certain biological and 
chemical elements. In a healthy state, this allows nutrients or signaling molecules from the 
23 
 
gastrointestinal milieu to flow into the bloodstream and/or pass between the brain and body. 
However, if these tightly regulated systems break down, increased barrier permeability can 
cause vulnerabilities to various forms of pathology. Fourth, both barriers continue to develop 
in the post-natal period and are considered most vulnerable during this early developmental 
stage (Saunders et al., 2012; van Elburg et al., 2003). 
 
Finally, both the gastrointestinal and blood-brain barriers are known to be regulated by the 
microbiota, at least in animal models. The microbiota closely regulates development of the 
gastrointestinal tract, with germ-free animals exhibiting profound structural and functional 
alterations in the intestinal barrier (for a review, see Sommer & Bäckhed, 2013). These 
include alterations in expression of tight junction proteins and mRNA (claudin-1 and 
occludin), elongated microvilli, and loss of the mucous layer, all of which may contribute to 
an observed increase in intestinal permeability (Hayes et al., 2018). More surprisingly, the 
microbiota has also been implicated in the development of the BBB (Braniste et al., 2014). 
Germ-free animals exhibit a striking increase in BBB permeability, starting in utero and 
continuing into adulthood. Loss of BBB integrity in GF animals was accompanied by reduced 
expression of the tight junction proteins occludin and claudin-5. Both intestinal and BBB 
permeability can be restored in GF animals by re-colonization in adulthood, pointing to a life-
long connection between barrier function and the gut microbiota (Braniste et al., 2014; Hayes 
et al., 2018). 
 
3.3 Immune System 
A growing literature is exploring the “neuro-immune axis” as its own bidirectional network 
or as a component of the microbiota-gut-brain axis (Irwin & Cole, 2011; Kraneveld et al., 
2014). Apart from regulating barrier function, inflammatory signals alter neural activity 
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through several mechanisms, including interactions with the HPA axis and vagus nerve as 
well as the direct action of cytokines in the brain. Cytokines are produced by many different 
cell types, including glia and neurons in the brain, and can also be actively transported across 
the blood-brain barrier following peripheral secretion. The levels of cytokines in the central 
nervous system can alter metabolism of various neurotransmitter systems (including 
serotonin, dopamine, and glutamate; Miller et al., 2013). In this manner, aberrant cytokine 
levels can disrupt the function of many important neurocircuits, including those involved in 
motivation and emotion (Miller et al., 2013). Certain cytokines can also act as growth factors 
and/or activate gene pathways involved in various basic cell functions (survival, migration, 
proliferation, differentiation, apoptosis), which are particularly vulnerable to disruption 
during development (Deverman & Patterson, 2009). It is therefore unsurprising that abnormal 
cytokine production (e.g., following maternal infection during pregnancy or in the case of 
allergy) is a risk factor for neurodevelopmental disorders (Garay & McAllister, 2010; van 
Sadelhoff et al., 2019). Thus, we can conclude that appropriate cytokine signaling and 
immune function is essential for neurodevelopment. 
 
Extending the neuro-immune axis to the gut microbiota, there is a growing understanding that 
the microbiota plays a critical role in development of the immune system. The 
gastrointestinal tract represents the largest immune interface in the body, and exposure to gut 
microbes is an important part of the process for training the immune system to distinguish 
harmful and innocuous stimuli and to subsequently mount appropriate responses to these 
different elements (Gensollen et al., 2016). Germ-free animals exhibit profound alterations in 
both innate and adaptive immunity (Strauch et al., 2005), while specific commensal bacteria 
can regulate the maturation of and balance between different types of T cells in vitro and in 
vivo (Baba et al., 2008; Ivanov et al., 2009; Sudo et al., 2002). Microbiota manipulations can 
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alter both circulating and central levels of cytokines (Burokas et al., 2017; Luczynski et al., 
2017; O'Mahony et al., 2005; Sudo et al., 2004) as well as microglia development (Erny et 
al., 2015; Thion et al., 2018b). Moreover, there is a growing realization of a link between 
immune/allergic sensitivity and alterations in the microbiota-gut-brain axis (Berni Canani et 
al., 2019). Finally, in keeping with the sensitive periods hypothesis, there also seem to be 
critical windows for both microbiota-immune interactions (as described in Section 1.2; Al 
Nabhani et al., 2019) and neural-immune interactions (for a review, see Thion et al., 2018a). 
 
3.4 Hypothalamic-Pituitary-Adrenal (HPA) Axis 
One of the seminal studies to investigate the role of the microbiota in brain development 
focused on the hypothalamic-pituitary-adrenal (HPA) axis stress response (Sudo et al., 2004). 
The study demonstrated that adult germ-free mice have an exaggerated HPA response to 
restraint stress, including elevated levels of ACTH and corticosterone (since replicated by 
Clarke et al., 2013). This effect could be attenuated or exacerbated by colonization with 
specific probiotic or pathogenic bacteria, respectively (Sudo et al., 2004). Re-colonization via 
fecal microbiota transfer from healthy mice also attenuated the HPA stress response. In 
keeping with our sensitive periods hypothesis, this strategy was only effective when the re-
colonization occurred by 6 weeks of age (Sudo et al., 2004). In terms of stress experienced 
during development, the microbiota has been shown to mediate the effects of early-life stress 
in the maternal separation model. Whereas conventionally colonized mice exhibit 
exaggerated anxiety- and depressive-like behaviors following maternal separation stress, 
germ-free mice are not affected by maternal separation with regards to these behaviors (De 
Palma et al., 2015).  Treatment with specific bacteria (Lactobacillus rhamnosus and 
Lactobacillus helveticus) was also effective at reversing the effects of maternal separation 
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stress on glucocorticoid production during development, both under basal conditions and in 
response to an acute stressor (Gareau et al., 2007; Peng et al., 2019).  
 
3.5 The Vagus Nerve 
The vagus nerve is considered to be the most direct route for signals from the microbiota to 
reach the brain (Fülling et al., 2019). It is the longest cranial nerve and consists of many 
branches that innervate the visceral organs, including the gastrointestinal tract, with both 
afferent (sensory) and efferent (motor) neurons. These fibers continue to develop across the 
first year of life in humans, with an increase in myelinated fibers (Pereyra et al., 1992). 
Signals from gastrointestinal vagal afferents reach the brain at the nucleus stria terminalis, 
which acts as a “relay station” through its projections to other brain regions, including many 
relevant to behavior (e.g., hypothalamus, amygdala, ventral tegmental area). Lesion of the 
vagus nerve prevents the behavioral effects of certain probiotics (Bravo et al., 2011; Sgritta et 
al., 2019). Most recently, it was shown that vagotomy at weaning prevented the rescue of 
social behavior by probiotic treatment in a genetic mouse model of autism (Sgritta et al., 
2019). 
 
4. Clinical Significance 
The above indications of the sensitivity of the microbiota-gut-brain axis during early 
development, with long-term effects on host health, have implications for various clinical 
conditions. Here, we will focus on neurodevelopmental disorders, although there is also 
substantial evidence that many other psychological disorders have developmental origins 
(Kessler et al., 2007; Lee et al., 2014) and are modulated by the microbiota (for reviews, see 




4.1 Microbiota and Neurodevelopmental Disorders 
The most concrete evidence for a role of the microbiota in any neurodevelopmental disorder 
is found in the study of autism spectrum disorders (ASD). A large proportion of individuals 
with ASD report comorbid gastrointestinal problems (Chaidez et al., 2014; Parracho et al., 
2005) and several observational studies have reported differences in the microbiota between 
children with ASD and neurotypical controls (Adams et al., 2011; Finegold et al., 2010; Kang 
et al., 2018; Kang et al., 2013; Parracho et al., 2005). Emerging experimental studies 
corroborate a more causal link between ASD symptoms and the microbiota, although all have 
been small studies and caution must therefore be taken in their interpretation. Fecal 
microbiota transplant from a small number of autistic individuals into germ free mice led to 
an emulation of aspects of autism (social deficits and increased repetitive behavior; Sharon et 
al., 2019). Three open-label pilot studies have demonstrated promising effects of antibiotics 
(Sandler et al., 2000), probiotics (Shaaban et al., 2017), or fecal microbiota transplants from 
healthy donors (Kang et al., 2019; Kang et al., 2017) as strategies to reduce symptom severity 
in ASD. Another three studies have used double-blind, placebo-controlled designs to assess 
different microbiota interventions. The initial trial of a 12-week probiotic treatment for 3-16 
year old children with ASD was plagued by a high drop-out rate, but still indicated some 
benefit of the treatment for bowel function and perhaps for behavioral symptoms as well 
(Parracho et al., 2010). Similar benefits for gastrointestinal and behavioral symptoms were 
observed in a dietary intervention that assessed an exclusion diet with or without a prebiotic 
supplement (Grimaldi et al., 2018). Both the diet and the prebiotic led to alterations in 
microbiota composition that correlated with fecal metabolite content. Interestingly, the 
behavioral changes were only observed in the group that received both the exclusion diet and 
the prebiotic, whereas the changes in gastrointestinal symptoms were driven by the exclusion 
diet. Finally, a preliminary trial (N = 75) of post-natal probiotic supplementation for the first 
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6 months of life found that treatment had a prophylactic effect, reducing the risk for ASD at 
13 years of age (Pärtty et al., 2015). 
 
In addition to reducing risk for ASD, postnatal probiotic treatment (Lactobacillus rhamnosus 
GG) also reduced risk for attention deficit hyperactivity disorder (ADHD; Pärtty et al., 2015). 
Diet has long been considered a contributing factor to ADHD symptomatology and a 
Western-style diet (high in processed meat, refined grains, fats and sugars) during 
adolescence has been linked to the disorder (Howard et al., 2011). Many dietary interventions 
have been trialed in ADHD with varying degrees of success, the most effective being 
elimination diets that exclude artificial food dyes (Jacobson & Schardt, 1999; Pelsser et al., 
2011). More direct examinations of the microbiota have shown that individuals with ADHD 
have a different microbiota profile compared to age-matched healthy controls (Aarts et al., 
2017; Prehn-Kristensen et al., 2018). Using a hypothesis-driven approach, it was identified 
that alterations in the predicted functionality of the microbiota along a dopamine pathway 
were associated with activity during a reward-based task (Aarts et al., 2017). These findings 
suggest that it is worthwhile to further evaluate the links between microbiota, diet and 
symptomatology in ADHD, especially in childhood. 
 
Finally, there has been much speculation about the role of the microbiota in schizophrenia. 
This relationship is particularly difficult to disentangle due to the almost ubiquitous use of 
antipsychotic medications, which are known to alter the microbiota. Nonetheless, some 
studies have identified differences in the oral and fecal microbiota of patients with 
schizophrenia, including particular taxa that correlated with symptom severity (Castro-Nallar 
et al., 2015; Zheng et al., 2019). Transplant of the fecal microbiota from patients into germ-
free mice induced hyperactivity and exaggerated startle responses as well as changes in 
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hippocampal glutamatergic function, but no changes in social behavior or pre-pulse inhibition 
(Zheng et al., 2019). In humans, probiotic interventions have thus far not shown any effect on 
symptom severity in this complex neurodevelopmental disorder (see Ng et al., 2019, for a 
systematic review of the 3 available studies, all with negative results). 
 
4.2 Challenges for Translation from Animals to Humans 
The state of the research has not yet reached the stage where recommendations can be made 
for the use of microbiota-based medicines or diagnostics in clinical settings. One of the chief 
limiting factors is the relative dearth of studies in humans and particularly in children. As 
discussed above, the evidence points to a link between the microbiota and both 
neurocognitive and psychological development but, with few exceptions, this evidence has 
been generated from animal models and/or correlational studies. While this is a common 
problem across many scientific fields, there are a few challenges that become acutely evident 
when considering the study of the microbiota-gut-brain axis during development.  
 
The study of such a complex whole-body system that incorporates multiple organs presents a 
number of challenges in itself. First, the complexity of interactions demands collaboration 
between experts in each system. There is a need for input from gastroenterologists, child 
psychologists/psychiatrists, microbiologists, and bioinformaticians to design appropriate 
experiments and ensure that the data is correctly analyzed. Second, this multiple-systems 
problem compounds the species differences within each individual system, which raises the 
barrier for translation of results from animal models. While rodents are the most common 
model system partly because they exhibit many similarities to humans in terms of both the 
brain and the gastrointestinal system, there are also clear differences in each component of 
the microbiota-gut-brain axis across species (Nguyen et al., 2015). For instance, the brain and 
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gastrointestinal tract are both simpler at a gross morphological level in rodents, while humans 
also have several distinct features such as the relative dominance of the cortical regions in the 
brain and the relatively small size of the cecum. 
 
Considering these systems across development introduces additional complexity due to 
variation in the developmental timelines across species. The trajectory of neurodevelopment 
is very different for humans and rodents; the rodent brain at birth is similar to that of a very 
premature infant (approximately the start of the third trimester; Clancy et al., 2007). Another 
clear example is the timing of weaning, a key event that we have discussed as relevant to 
potential critical windows of microbiota-gut-brain development but which happens at 
different stages of brain development in rodents and humans. Young rodents begin to ingest 
solid food around postnatal day (P) 16 and are fully weaned by P21 (Londei et al., 1988). For 
human children, the World Health Organization recommends introduction of semi-solid 
foods from 6 months of age, with a completely solid diet at 18-24 months (World Health 
Organization, 2005). However, equating P16 in a rodent to 6 months in a human does not 
necessarily match on to estimates of neurodevelopment, which can vary wildly depending on 
the metric of interest. For example, some place a P16 rodent at the equivalent of 2-3 human 
months based on physical characteristics (Clancy et al., 2007), or more than 2 human years 
based on development of attachment relationships and fear neurocircuitry (Callaghan et al., 
2019). Thus, it will be important to consider the specific developmental trajectories of 
different aspects of neurodevelopment when attempting to predict how studies of the 
microbiota in model species will translate to humans. 
 
Another factor that warrants further attention is the impact of sex. Certainly, there are clear 
sex differences in the prevalence of neurodevelopmental disorders, with ASD, ADHD, and 
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schizophrenia being more common in males. The microbiota contribution to such sex 
differences in neuropsychological function is largely unknown, despite strong arguments to 
support further investigation and some intriguing preliminary findings (Audet, 2019; 
Jašarević et al., 2016). In rodents, there are now several examples where more pronounced 
effects of early microbiota disruption have been observed in males compared to females 
(Clarke et al., 2013; Desbonnet et al., 2014; Hoban et al., 2016b; Jašarević et al., 2017; but 
see also complex sex-specific effects described by Luk et al., 2018). For example, prenatal 
stress has more profound effects on the developing male microbiota (Jašarević et al., 2017; 
Jašarević et al., 2015), while germ-free males but not females exhibit hypermyelination of the 
prefrontal cortex (Hoban et al., 2016b) and disruption of the hippocampal serotonergic 
system (Clarke et al., 2013). Similarly, maternal germ-free status had a substantially greater 
impact on the microglia of males during embryonic development (>1,000 genes differentially 
expressed in male microglia vs 20 genes in females), although this sex difference was 
reversed in adulthood (Thion et al., 2018b). Following a fecal microbiota transplant from 
children with ASD, stronger behavioral deficits were observed in male recipient mice than in 
females (Sharon et al., 2019). In healthy children, two studies tested for but did not detect sex 
differences in the composition of the developing microbiota (Carlson et al., 2018; Stewart et 
al., 2018). However, interactions between sex and microbiota-relevant outcomes have been 
reported in at least two observational studies. In the first, the effects of prematurity on 
cognitive performance was stronger in boys, who also showed greater improvement with a 
dietary intervention (Lucas et al., 1998). In the other (Aatsinki et al., in press), associations 
between microbiota composition and temperament were stronger in boys (Aatsinki et al., in 
press; although this sex effect was not observed in a smaller, less well-powered study 
examining the same variables; Christian et al., 2015). Thus, the preliminary findings hint that 
males may be more vulnerable to the effects of microbiota manipulations on 
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neurodevelopment, in keeping with the pattern of sex differences observed for 
neurodevelopmental disorders. 
 
The sheer size of the datasets generated by sequencing technologies can be bewildering to 
most experimental researchers. The vast majority of microbiota members are not well-
characterized at the species or strain level, leaving large gaps in our knowledge regarding 
their function and relative importance. Databases are developing at a rapid rate in an attempt 
to close these gaps, but this requires vigilant updating and maintenance of the databases and 
techniques used to analyze them, impeding direct comparison between studies. When 
choosing methods to manipulate the microbiota in humans, more consideration needs to be 
given to choices of probiotic, dosage titration (particularly across development), method of 
administration, and target population (with some evidence that microbiota-based 
interventions are more useful when there is a pre-existing imbalance in the microbiota-gut-
brain axis; Ng et al., 2018).  
 
5. Conclusions  
The field is beginning to narrow the gaps in terms of our understanding of the pathways that 
allow communication along the microbiota-gut-brain axis. More work is needed to fine-tune 
this knowledge and understand the boundary conditions for when specific pathways are most 
important. This mechanistic approach needs to be complemented with more translational 
studies to test the relevance of evidence produced by animal models for humans. In 
particular, studies examining sex differences, clinical populations, and prospective 
longitudinal cohorts are needed to assess the dynamic contribution of the microbiota to 
neuropsychological and clinical outcomes. Based on the evidence for potential sensitive 
periods in the microbiota-gut-brain axis, investigations focused on early development could 
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be a fruitful approach for gaining traction in harnessing the potential of the microbiota for 
treatment of psychological or cognitive problems. 
 
Key Points 
• The gut microbiota, or the collection of microorganisms that inhabit the 
gastrointestinal tract, have been shown to affect cognitive and behavioral outcomes 
across species 
• The microbiota-gut-brain axis is made up of many pathways through which the 
microbiota and brain can communicate in a bidirectional manner 
• We propose that developmental transitions in the microbiota may represent key 
sensitive periods during which the microbiota-gut-brain axis is most vulnerable, but 
also most malleable to intervention 
• More work is needed to test the translational value of evidence gathered from animal 
models regarding the potential for targeting the microbiota in neurodevelopmental and 
psychological disorders, particularly in developing populations 
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